Evidence map›Paper›PMID 23180366›Full record

ArticleInflammation2013

Suppression of MAPK and NF-κB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury.

Gefu Chi, Miaomiao Wei, Xianxing Xie, L W Soromou, Fang Liu, Shuhua Zhao

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 117 citations in OpenAlex.

  1. Food science & nutrition · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Related Mechanism of Limonene Improves LPS-Induced Neuroinflammation.Journal of microbiology and biotechnology · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Exploration of the anti-inflammatory potential ofFrontiers in pharmacology · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Gefu ChiDepartment of Outpatient Clinic, the Affiliated Hospital of Inner Mongolia University for the Nationalities, Tongliao, 028000, People's Republic of China.
Miaomiao Wei
Xianxing Xie
L W Soromou
Fang Liu
Shuhua Zhao
Jilin University · CNInner Mongolia University for Nationalities · CNSecond Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate the protective role of limonene in lipopolysaccharide (LPS)-induced acute lung injury (ALI). ALI was induced in mice by intratracheal instillation of LPS (0.5 mg/kg), and limonene (25, 50, and 75 mg/kg) was injected intraperitoneally 1 h prior to LPS administration. After 12 h, bronchoalveolar lavage fluid (BALF) and lung tissue were collected. Limonene pretreatment at doses of 25, 50, and 75 mg/kg decreased LPS-induced evident lung histopathological changes, lung wet-to-dry weight ratio, and lung myeloperoxidase activity. In addition, pretreatment with limonene inhibited inflammatory cells and proinflammatory cytokines including tumor necrosis factor-α, interleukin-1β, and interleukin-6 in BALF. Furthermore, we demonstrated that limonene blocked the phosphorylation of IκBα, nuclear factor-κB (NF-κB) p65, p38 mitogen-activated protein kinase (MAPK), c-Jun NH2-terminal kinase, and extracellular signal-regulated kinase in LPS-induced ALI. The results presented here suggest that the protective mechanism of limonene may be attributed partly to decreased production of proinflammatory cytokines through the inhibition of NF-κB and MAPK activation.

Indexed as

Acute Lung InjuryAnimalsAnti-Inflammatory AgentsBronchoalveolar Lavage FluidCyclohexenesDexamethasoneInflammationInterleukinsLimoneneLipopolysaccharidesLungMaleMAP Kinase Signaling SystemMiceMice, Inbred BALB CMitogen-Activated Protein KinasesAnti-Inflammatory AgentsCyclohexenesDexamethasoneInterleukinsLimoneneLipopolysaccharidesMitogen-Activated Protein KinasesNF-kappa BNF-kappa B p50 SubunitNfkb1 protein, mousePeroxidaseRela protein, mouseTerpenesTranscription Factor RelATumor Necrosis Factor-alpha

Identifiers

PMID23180366
OpenAlexW2144245184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.